Virtual Reality and Social Cognition After Acquired Brain Injury
1 other identifier
observational
200
1 country
1
Brief Summary
The study aim is to improve assessment and understanding of social cognitive impairment after acquired brain injury by developing and validating a virtual reality version of The Awareness of Social Inference Test (TASIT). It is expected that the VR version of the test has comparable or better psychometric properties than the video version, and that it has improved relevance to everyday social skills. It is also expected that the VR version taxes cognitive functions more than a desktop version with identical content as the VR version.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2022
CompletedFirst Posted
Study publicly available on registry
April 4, 2022
CompletedStudy Start
First participant enrolled
September 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedNovember 10, 2022
November 1, 2022
1.2 years
March 24, 2022
November 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Known Groups Validity of VR TASIT assessed with Mann Whitney U test
It is expected that the patient group performs poorer than the control group on the VR TASIT, both total score and scores on each of the three subtests.
60 minutes
Reliability of VR TASIT in the patient group assessed with paired sample t-tests
The test-retest reliability of VR TASIT in the patient group is determined by re-administering the test 16 weeks after the first administration and calculating the correlation. Analysis of both total score and subscores will be conducted.
60 minutes
Secondary Outcomes (3)
Convergent Validity of VR TASIT in the patient group assessed with paired sample t-tests.
60 minutes
Divergent Validity of VR TASIT in the patient group assessed with paired sample t-tests.
60 minutes
Ecological Validity of VR TASIT assessed with paired sample t-tests.
60 minutes
Other Outcomes (2)
Secondary Ecological Validity of VR TASIT assessed with paired sample t-tests.
60 min
Presence of VR TASIT versus DT TASIT in patient group assessed with paired sample t-test
60 minutes
Study Arms (2)
ABI group
The patient group consists of 100 patients with acquired brain injury (e.g. cerebrovascular incidents, anoxia, encephalitis and non-progressive brain tumors)
Healthy control group
100 healthy adults will be matched to the patients with respect to age, gender and education.
Interventions
Consists of a Norwegian adaptation of the 59 videos of social scenes that constitute the A Form in the original TASIT. The stimulus material in the Virtual Reality version is perceived through a head mounted display. This allows the test person to watch the scenes in three dimensions and a 360 degree angle, increasing the sense of social presence.
Consists of a Norwegian adaptation of the 59 videos of social scenes that constitute the A Form in the original TASIT, with identical content as the VR TASIT. The stimulus material in the desktop version is perceived on a two dimensional desktop computer screen.
Eligibility Criteria
Acquired Brain Injury
You may qualify if:
- Patients in stable phase after acquired brain injury, minimum one year after injury
- Physically able to operate VR technology
- Norwegian skills adequate to understand instructions and dialogues in TASIT videos.
You may not qualify if:
- Severe aphasia affecting their understanding of instructions
- Apraxia affecting their ability to use VR-equipment
- Visual neglect
- Severe mental illness or co-existing neurological disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sunnaas Rehabilitation Hospital
Nesoddtangen, Akershus, 1453, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marianne Løvstad, Professor
Sunnaas Rehabilitation Hospital and University of Oslo
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2022
First Posted
April 4, 2022
Study Start
September 15, 2022
Primary Completion
December 1, 2023
Study Completion
December 1, 2024
Last Updated
November 10, 2022
Record last verified: 2022-11